Agios Pharma's market cap is currently $1.93B. The company's EPS TTM is $11.395; its P/E ratio is 2.96; Agios Pharma is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $-1.76. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 36.50M	$ 26.82M	$ 14.24M	$ 0.00	$ 203.20M
Gross Profit	$ 32.33M	$ 17.32M	$ 12.54M	$ -18.78M	$ 200.39M
Operating Income	$ -425.74M	$ -391.49M	$ -389.05M	$ -378.42M	$ -316.15M
EBITDA	$ -425.74M	$ -384.86M	$ -380.48M	$ -337.73M	$ -326.13M
Net Income	$ 673.73M	$ -352.09M	$ -74.56M	$ 1.60B	$ -335.22M
Balance Sheet
Cash & Short-Term Investments	$ 893.71M	$ 776.93M	$ 1.10B	$ 1.29B	$ 670.54M
Total Assets	$ 1.66B	$ 937.12M	$ 1.24B	$ 1.44B	$ 852.95M
Total Debt	$ 56.99M	$ 72.00M	$ 85.66M	$ 97.09M	$ 105.20M
Net Debt	$ -19.26M	$ -16.21M	$ -53.60M	$ -106.03M	$ -22.24M
Total Liabilities	$ 122.24M	$ 126.10M	$ 137.90M	$ 145.76M	$ 453.45M
Stockholders' Equity	$ 1.54B	$ 811.02M	$ 1.10B	$ 1.29B	$ 399.50M
Cash Flow
Free Cash Flow	$ -391.53M	$ -297.06M	$ -314.36M	$ -413.06M	$ -305.67M
Operating Cash Flow	$ -389.84M	$ -296.06M	$ -309.48M	$ -407.32M	$ -290.76M
Investing Cash Flow	$ 363.44M	$ 239.57M	$ 243.26M	$ 1.25B	$ 75.75M
Financing Cash Flow	$ 14.44M	$ 5.43M	$ 2.35M	$ -765.77M	$ 261.52M

Currency in USD

Agios Pharma Earnings and Revenue History

Income Statement >

Agios Pharma Debt to Assets

Balance Sheet >

Agios Pharma Cash Flow

Cash Flow >

Agios Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing